EQWL Invesco S&P 100 Equal Weight ETF

Expense Ratio
0.25%
Dividend
1.58%
Previous close
$124.56
Est. 12 months change
-15.95%
Projected Price
$104.69

Profitability Metrics

Return on Equity (ROE)
37.96%
Return on Assets (ROA)
9.25%
Return on Invested Capital (ROIC)
24.65%
Weighted Average Cost of Capital (WACC)
8.41%
ROIC - WACC
16.24%
Updated : 2026-05-18 18:48 ET

Valuation Metrics

P/E Ratio
24.21
Forward P/E
18.28
PEG Ratio
2.05
Debt Current Ratio
1.50

Growth & Cash Flow

Gross Margin
53.19%
Operating Margin
25.87%
FCF Margin
20.40%
TTM Revenue Growth
16.25%
Projected 12M EPS Growth
32.47%

Price Change

Price % from 50 SMA
4.15%
Price % from 200 SMA
6.04%
6 Months
8.82%
1 Year
16.86%
2 Years
31.06%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
INTC2.31%
AMD2.10%
MU1.77%
TXN1.48%
QCOM1.42%
CSCO1.41%
UNH1.33%
LRCX1.30%
CAT1.24%
AVGO1.23%

ETF Analysis

Fund Overview

Invesco S&P 100 Equal Weight ETF (EQWL) currently reports 101 stock positions (subject to change), placing it in the widely spread range by holdings breadth. The top line-up is INTC (2.31%), AMD (2.10%), MU (1.77%), with INTC as the largest single weight at 2.31%. Together, the top three holdings account for 6.18%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 24.65%, WACC is 8.41%, and the economic spread is 16.24%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 37.96% and ROA at 9.25%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The portfolio's current market valuation reflects trailing P/E of 24.21, forward P/E of 18.28, PEG of 2.05. The trailing-to-forward compression is present but not extreme — consistent with a portfolio where earnings are expected to grow at a steady rather than exceptional pace. The PEG reads as moderate — investors are paying a fair but not discounted price for the growth embedded in current estimates. The current ratio of 1.50 is in an acceptable range, reflecting reasonable short-term financial health. Across multiples and liquidity, the portfolio is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 53.19%, operating margin at 25.87%, and free cash flow margin at 20.40%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. All three margin layers are constructive, pointing to a portfolio where quality of earnings is high and cash generation is reliable.

Growth & Forward Outlook

Projected 12-month EPS growth of 32.5% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 16.25% pointing to stable operational progress without outsized acceleration, while the estimated 12-month price change of -16.11%, where the target profile indicates a negative expected price trajectory. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Taken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.